Inventor · disambiguated record
Robert M. Grotzfeld
Also filed as: GROTZFELD ROBERT M · GROTZFELD ROBERT MARTIN
12 granted patents·15 pending applications·97 citations·filing 2004–2022
90Inventor score
Top patents by PatentIndex Score
27 records- 0193US8129374B2Method of using imidazolothiazole compounds for the treatment of diseaseBHAGWAT SHRIPAD·Filed 2010·Granted Mar 6, 2012·34 cites·42 claims
- 0290US7820657B2Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2007·Granted Oct 26, 2010·13 cites·37 claims
- 0386US8829195B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1DODD STEPHANIE KAY·Filed 2013·Granted Sep 9, 2014·16 cites·16 claims
- 0485US9340537B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted May 17, 2016·4 cites·3 claims
- 0585US9278981B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Mar 8, 2016·6 cites·18 claims
- 0683US7750160B2Isoxazolyl urea derivatives as kinase modulatorsAMBIT BIOSCIENCES CORP·Filed 2004·Granted Jul 6, 2010·17 cites·31 claims
- 0772US9498540B2Cell proliferation inhibitors and conjugates thereofBARSANTI PAUL A·Filed 2014·Granted Nov 22, 2016·2 cites·5 claims
- 0870US8557810B2Imidazolothiazole compounds for the treatment of diseaseBHAGWAT SHRIPAD·Filed 2012·Granted Oct 15, 2013·1 cites·22 claims
- 0970US7767670B2Substituted 3-carboxamido isoxazoles as kinase modulatorsAMBIT BIOSCIENCES CORP·Filed 2004·Granted Aug 3, 2010·4 cites·24 claims
- 1064US2015126505A1Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2014·Application pending·0 cites
- 1161US2005153989A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 1261US2017348320A1Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2017·Application pending·0 cites
- 1361US2005165029A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 1458US2018134695A1Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1FURET PASCAL·Filed 2018·Application pending·0 cites
- 1557US9896444B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2016·Granted Feb 20, 2018·0 cites·5 claims
- 1657US2024216513A1Fatty acid-bifunctional degrader conjugates and their methods of useNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1757US2010048890A1Conjugated small moleculesGROTZFELD ROBERT M·Filed 2009·Application pending·0 cites
- 1856US2005239806A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 1953US2005187389A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 2053US2004248957A1Heterocyclic compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 2153US2004242673A1Heterocyclic compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 2251US9458112B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2016·Granted Oct 4, 2016·0 cites·8 claims
- 2350US9315489B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Apr 19, 2016·0 cites·20 claims
- 2448US2014343086A1Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1DODD STEPHANIE KAY·Filed 2014·Application pending·0 cites
- 2547US2005153371A1Conjugated small moleculesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 2645US2010173917A1Urea derivatives as abl modulatorsAMBIT BIOSCIENCES CORP·Filed 2010·Application pending·0 cites
- 2744US2017326250A1Cell proliferation inhibitors and conjugates thereofBARSANTI PAUL ANDREW·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →